Therapeutic experience with ticarcillin disodium plus potassium clavulanate in the Federal Republic of Germany--results of a multicentre-study.
Three hundred and eighty protocols of a multicentre study of ticarcillin plus clavulanic acid were evaluated. Patients with a multitude of severe infections were treated. Therapy with the drug combination was successful in 89% of the cases. The drug was tolerated very well. No severe adverse reactions were attributable to the test drug.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000469:Alkaline Phosphatase / Q000097:blood; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use*; D011517:Prothrombin Time; D013982:Ticarcillin / Q000627:therapeutic use*
D002969:Clavulanic Acids; D010406:Penicillins; D019818:Clavulanic Acid; D000469:Alkaline Phosphatase; D013982:Ticarcillin